IC
VAXX

IEQ Capital’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

IEQ Capital’s Portfolio VAXX Stock Details VAXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-83,262
Closed -$59.7K – 1046
2024
Q1 		$59.7K Hold
83,262
– – ﹤0.01% 943
2023
Q4 		$70.8K Buy
+83,262
New +$80.4K ﹤0.01% 896

Other funds holding VAXX

SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
RF
Robinswood Financial Kirkland, Washington $349M AUM 14.9% 1-Year Est. Return

IEQ Capital's VAXX Position: Q2 2024 in Review

IEQ Capital sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q2 2024, closing a stake of 83,262 shares — an estimated $59.7K sold.

IEQ Capital first reported a position in VAXX in Q4 2023 and held it in 2 quarters. The position peaked at $70.8K in Q4 2023. 8 funds tracked by Wall St. Rank hold VAXX as of Q2 2024.

  • IEQ Capital reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
  • IEQ Capital sold 83,262 Vaxxinity, Inc. Class A Common Stock shares in Q2 2024, an estimated $59.7K.
  • IEQ Capital first reported a position in Vaxxinity, Inc. Class A Common Stock in Q4 2023 and held it in 2 quarters.
  • IEQ Capital's Vaxxinity, Inc. Class A Common Stock position peaked at $70.8K in Q4 2023.
  • 8 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q2 2024.

Based on IEQ Capital's 13F filing for Q2 2024, filed 12 Aug 2024.